These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24906060)

  • 21. Crossover studies with survival outcomes.
    Buyze J; Goetghebeur E
    Stat Methods Med Res; 2013 Dec; 22(6):612-29. PubMed ID: 21715438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of noise and lipid signals on determination of Gaussian and non-Gaussian diffusion parameters in skeletal muscle.
    Cameron D; Bouhrara M; Reiter DA; Fishbein KW; Choi S; Bergeron CM; Ferrucci L; Spencer RG
    NMR Biomed; 2017 Jul; 30(7):. PubMed ID: 28383778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of statistical methods for clustered data analysis with Gaussian error.
    Feng Z; McLerran D; Grizzle J
    Stat Med; 1996 Aug; 15(16):1793-806. PubMed ID: 8870161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporating baseline measurements into the analysis of crossover trials with time-to-event endpoints.
    Xu R; Mehrotra DV; Shaw PA
    Stat Med; 2018 Oct; 37(23):3280-3292. PubMed ID: 29888552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective assessment of frequency distribution histograms and consequences on reference interval accuracy for small sample sizes: A computer-simulated study.
    Coisnon C; Mitchell MA; Rannou B; Le Boedec K
    Vet Clin Pathol; 2021 Sep; 50(3):427-441. PubMed ID: 34476826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A note on misspecification in general linear models with correlated errors for the analysis of crossover clinical trials.
    Wang W; Cong N; Chen T; Zhang H; Zhang B
    PLoS One; 2019; 14(3):e0213436. PubMed ID: 30870443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the role of Baseline measurements for crossover designs under the self and mixed carryover effects model.
    Liang Y; Carriere KC
    Biometrics; 2010 Mar; 66(1):140-8. PubMed ID: 19432775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating correlation with multiply censored data arising from the adjustment of singly censored data.
    Newton E; Rudel R
    Environ Sci Technol; 2007 Jan; 41(1):221-8. PubMed ID: 17265951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ways to fit a PK model with some data below the quantification limit.
    Beal SL
    J Pharmacokinet Pharmacodyn; 2001 Oct; 28(5):481-504. PubMed ID: 11768292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biases.
    Flandre P; Durier C; Descamps D; Launay O; Joly V
    J Acquir Immune Defic Syndr; 2002 May; 30(1):59-64. PubMed ID: 12048363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of several methods for analyzing censored data.
    Hewett P; Ganser GH
    Ann Occup Hyg; 2007 Oct; 51(7):611-32. PubMed ID: 17940277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of mid-point imputation on the analysis of doubly censored data.
    Law CG; Brookmeyer R
    Stat Med; 1992 Sep; 11(12):1569-78. PubMed ID: 1439361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the agreement of biomarker data in the presence of left-censoring.
    Domthong U; Parikh CR; Kimmel PL; Chinchilli VM;
    BMC Nephrol; 2014 Sep; 15():144. PubMed ID: 25186769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical power and estimation of incidence rate ratios obtained from BED incidence testing for evaluating HIV interventions among young people.
    Auvert B; Mahiane GS; Lissouba P; Moreau T
    PLoS One; 2011; 6(8):e21149. PubMed ID: 21853019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects.
    DeWees TA; Mazza GL; Golafshar MA; Dueck AC
    Value Health; 2020 May; 23(5):625-631. PubMed ID: 32389228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A generalization of Turnbull's estimator for nonparametric estimation of the conditional survival function with interval-censored data.
    Dehghan MH; Duchesne T
    Lifetime Data Anal; 2011 Apr; 17(2):234-55. PubMed ID: 20544280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast genomic predictions via Bayesian G-BLUP and multilocus models of threshold traits including censored Gaussian data.
    Kärkkäinen HP; Sillanpää MJ
    G3 (Bethesda); 2013 Sep; 3(9):1511-23. PubMed ID: 23821618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of statistical methods for estimating the lower limit of detection.
    Huang S; Wang T; Yang M
    Assay Drug Dev Technol; 2013 Feb; 11(1):35-43. PubMed ID: 22574654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian semiparametric mixture Tobit models with left censoring, skewness, and covariate measurement errors.
    Dagne GA; Huang Y
    Stat Med; 2013 Sep; 32(22):3881-98. PubMed ID: 23553914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.